Yang Ling, Yang Letian, Zhao Yuliang, Wang Yating, Yu Yang, Salerno Stephen, Li Yi, Fu Ping, Cui Tianlei
Outpatient Department, West China Hospital of Sichuan University, Chengdu, China.
Division of Nephrology, West China Hospital of Sichuan University, Chengdu, China.
Hemodial Int. 2020 Jan;24(1):52-60. doi: 10.1111/hdi.12804. Epub 2019 Dec 6.
Hemodialysis catheter-related superior vena cava (SVC) occlusions can cause considerable morbidity for patients and be challenging to treat if refractory to conventional guide wire transversal. This pilot study assessed the feasibility and safety of sharp recanalization of SVC occlusion in hemodialysis patients.
This study retrospectively enrolled hemodialysis patients treated in West China Hospital diagnosed with SVC occlusion who failed traditional guide wire transversal from January 2014 to November 2017. In brief, a guide wire from the femoral approach was advanced to the lower end of the obstructive lesion to act as a target, while the stiff end of hydrophilic wire was advanced though a jugular approach. Under fluoroscopic guidance in biplane imaging, the occlusive SVC lesion was penetrated with the stiff wire that was snared and pulled through. Graded dilation of the SVC and subsequent tunneled-cuffed catheter implantation were performed. Demographic information and clinical outcomes were recorded and evaluated.
Sixteen patients with a mean age of 62 ± 13 years (13 females and 3 males) who received SVC sharp recanalization were included in this study. The sharp recanalization procedure was successfully performed in 14 patients (87.5%). Two patients were complicated with SVC laceration and hemopericardium but remained asymptomatic and required no surgical repair. One patient suffered ventricular fibrillation during procedure. Despite the return of spontaneous circulation, the patient unfortunately died of gastrointestinal tract bleeding after 3 days in ICU. Follow-up suggested the 6-month catheter patency to be 92.85% and 12-month catheter patency to be 58.33%. No long-term procedure-related complications were recorded.
Sharp recanalization might be a feasible strategy in managing SVC occlusion in hemodialysis patients. The potential life-threatening complications (cardiac arrhythmia and SVC laceration) necessitate strict eligibility screening, skillful operation, and avoidance of over-dilation of SVC.
血液透析导管相关的上腔静脉(SVC)闭塞会给患者带来相当大的发病率,如果对传统导丝横向穿过无效,则治疗具有挑战性。这项前瞻性研究评估了血液透析患者SVC闭塞锐性再通的可行性和安全性。
本研究回顾性纳入了2014年1月至2017年11月在华西医院接受治疗、诊断为SVC闭塞且传统导丝横向穿过失败的血液透析患者。简而言之,从股动脉途径推进一根导丝至阻塞性病变的下端作为靶点,同时通过颈静脉途径推进亲水导丝的硬端。在双平面成像的荧光透视引导下,用硬导丝穿透闭塞的SVC病变,将其圈套并拉出。对SVC进行分级扩张,随后植入带隧道的带 cuff 导管。记录并评估人口统计学信息和临床结果。
本研究纳入了16例接受SVC锐性再通的患者,平均年龄为62±13岁(13例女性和3例男性)。14例患者(87.5%)成功进行了锐性再通手术。2例患者并发SVC撕裂和心包积血,但仍无症状,无需手术修复。1例患者在手术过程中发生心室颤动。尽管恢复了自主循环,但该患者在重症监护病房3天后不幸死于胃肠道出血。随访显示6个月导管通畅率为92.85%,12个月导管通畅率为58.33%。未记录到长期的手术相关并发症。
锐性再通可能是治疗血液透析患者SVC闭塞的一种可行策略。潜在的危及生命的并发症(心律失常和SVC撕裂)需要严格的入选标准筛选、熟练的操作以及避免SVC过度扩张。